Elekta AB (publ) (OTCMKTS:EKTAY) Short Interest Up 75.0% in June

Elekta AB (publ) (OTCMKTS:EKTAY) saw a significant growth in short interest in the month of June. As of June 15th, there was short interest totalling 2,100 shares, a growth of 75.0% from the May 31st total of 1,200 shares. Based on an average daily trading volume, of 32,800 shares, the short-interest ratio is presently 0.1 days.

Elekta AB (publ) Price Performance

Shares of EKTAY stock traded down $0.05 on Friday, hitting $6.15. 27,199 shares of the stock were exchanged, compared to its average volume of 15,892. The company has a quick ratio of 0.76, a current ratio of 1.00 and a debt-to-equity ratio of 0.45. The business has a 50-day moving average of $7.08 and a 200 day moving average of $7.37. Elekta AB has a fifty-two week low of $6.04 and a fifty-two week high of $8.62.

Elekta AB (publ) (OTCMKTS:EKTAY) last posted its quarterly earnings data on Wednesday, June 5th. The company reported $0.11 earnings per share for the quarter. The company had revenue of $475.78 million during the quarter. Elekta AB (publ) had a return on equity of 13.27% and a net margin of 7.19%. Equities analysts expect that Elekta AB will post 0.42 EPS for the current year.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.